About Genentech
Genentech is a company based in San Francisco (United States) founded in 1976 was acquired by Roche in March 2009.. Genentech has completed 5 acquisitions, including Jecure Therapeutics, MyVisionTrack and RQX Pharmaceuticals. Genentech offers products and services including Medicines and Clinical Trials. Genentech operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genentech, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$404.2 K (USD), Grant
Sep 22, 2023
-
Investors
Roche
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Jecure Therapeutics
& 4 more
-
Acquired by
Roche
(Mar 12, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genentech
Genentech offers a comprehensive portfolio of products and services, including Medicines and Clinical Trials. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for oncology and other diseases
Conducts studies for new therapies and patient support
Unlock access to complete
Unlock access to complete
Leadership Team
146 people
Software Development Team
120 people
Product Management Team
79 people
Senior Team
63 people
Sales and Marketing
48 people
Data Analysis and Operations Team
44 people
Principal Team
27 people
Legal and Compliance
26 people
Unlock access to complete
Funding Insights of Genentech
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $404,201
-
First Round
First Round
(22 Sep 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Grant - Genentech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genentech
Genentech has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Roche and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genentech
Genentech has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Jecure Therapeutics, MyVisionTrack and RQX Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for NASH and liver fibrosis are discovered and developed.
|
2015 | ||||
|
Selective estrogen receptor degraders are developed for breast cancer treatment.
|
2013 | ||||
|
Novel antibiotics for community and hospital infections are developed.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Genentech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genentech Comparisons
Competitors of Genentech
Genentech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genentech
Frequently Asked Questions about Genentech
When was Genentech founded?
Genentech was founded in 1976 and raised its 1st funding round 47 years after it was founded.
Where is Genentech located?
Genentech is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
What does Genentech do?
Genentech was founded in 1976 in San Francisco, United States, as a biotechnology firm. Research and development efforts are directed toward manufacturing pharmaceutical products across multiple therapeutic areas, including oncology, immunology, neurology, metabolism, infectious diseases, and ophthalmology. Clinical trial information services are also offered to support medical research and development activities in the sector.
Who are the top competitors of Genentech?
Genentech's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Genentech offer?
Genentech offers Medicines and Clinical Trials.
How many acquisitions has Genentech made?
Genentech has made 5 acquisitions, including Jecure Therapeutics, MyVisionTrack, and RQX Pharmaceuticals.